RT info:eu-repo/semantics/article
T1 Phase angle as a prognostic indicator of survival in institutionalized psychogeriatric patients
A1 Barrera Ortega, Sara
A1 Redondo del Río, María Paz
A1 Carreño Enciso, Laura
A1 Cruz Marcos, Sandra de la
A1 Massia, María Noel
A1 Mateo Silleras, Beatriz de
K1 Bioelectrical impedance
K1 Impedancia (Electricidad)
K1 Phase angle
K1 Dementia
K1 Demencia
K1 Schizophrenia
K1 Esquizofrenia
K1 Geriatric psychiatry
K1 Psychiatry
K1 Personas de edad - Cuidado e higiene
K1 Personas de edad - Protección, asistencia, etc
K1 Nutrition - Evaluation
K1 Nutrición - Evaluación
K1 Survival
K1 Supervivencia
K1 3211 Psiquiatría
K1 3201.07 Geriatría
K1 6108 Psicología de la Vejez
K1 3206 Ciencias de la Nutrición
AB Phase angle (PhA) has been evidenced to be a useful survival indicator and predictor of morbi-mortality in different pathologies, but not in psychogeriatric patients. The aim of this study was to evaluate the clinical utility of PhA as a prognostic indicator of survival in a group of institutionalized psychogeriatric patients. A survival study was conducted on 157 patients (46.5% dementia, 43.9% schizophrenia). Functional impairment stage, frailty, dependence, malnutrition (MNA), comorbidity, polypharmacy, BMI, and waist circumference were registered. Body composition was analyzed using a 50-kHz whole-body BIA; PhA was recorded. The association between mortality and standardized-PhA was evaluated through univariate and multivariate Cox regression models and ROC-curve. The risk of death decreased when Z-PhA, BMI, and MNA were higher. Mortality increases with age, frailty, and dependence. The risk of death was statistically significantly lower (56.5%) in patients with schizophrenia vs. dementia (89%). The Z-PhA cut-off point was −0.81 (Sensitivity:0.75; Specificity:0.60). Mortality risk was multiplied by 1.09 in subjects with a Z-PhA < −0.81, regardless of age, presence of dementia, and BMI. PhA presented a remarkable clinical utility as an independent indicator of survival in psychogeriatric patients. Moreover, it could be useful to detect disease-related malnutrition and to identify subjects eligible for an early clinical approach.
PB MDPI
SN 2072-6643
YR 2023
FD 2023
LK https://uvadoc.uva.es/handle/10324/64351
UL https://uvadoc.uva.es/handle/10324/64351
LA eng
NO Nutrients, 2023, Vol. 15, Nº. 9, 2139
NO Producción Científica
DS UVaDOC
RD 14-oct-2024